Tabula Rasa HealthCare, Inc.
TRHC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $300 | $331 | $297 | $285 |
| % Growth | -9.6% | 11.5% | 4.4% | – |
| Cost of Goods Sold | $233 | $233 | $205 | $181 |
| Gross Profit | $67 | $98 | $92 | $103 |
| % Margin | 22.3% | 29.6% | 31.1% | 36.3% |
| R&D Expenses | $14 | $20 | $18 | $22 |
| G&A Expenses | $75 | $74 | $65 | $51 |
| SG&A Expenses | $85 | $100 | $87 | $76 |
| Sales & Mktg Exp. | $10 | $26 | $22 | $25 |
| Other Operating Expenses | $23 | $48 | $45 | $34 |
| Operating Expenses | $123 | $167 | $150 | $132 |
| Operating Income | -$56 | -$69 | -$58 | -$29 |
| % Margin | -18.8% | -20.9% | -19.4% | -10.1% |
| Other Income/Exp. Net | -$21 | -$9 | -$21 | -$16 |
| Pre-Tax Income | -$77 | -$78 | -$86 | -$49 |
| Tax Expense | $0 | $1 | -$5 | -$16 |
| Net Income | -$77 | -$79 | -$81 | -$32 |
| % Margin | -25.8% | -23.9% | -27.2% | -11.4% |
| EPS | -3.18 | -3.39 | -3.71 | -1.57 |
| % Growth | 6.2% | 8.6% | -136.3% | – |
| EPS Diluted | -3.18 | -3.39 | -3.71 | -1.57 |
| Weighted Avg Shares Out | 24 | 23 | 22 | 21 |
| Weighted Avg Shares Out Dil | 24 | 23 | 22 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9 | $9 | $21 | $16 |
| Depreciation & Amortization | $32 | $48 | $45 | $34 |
| EBITDA | -$27 | -$22 | -$20 | $2 |
| % Margin | -9.1% | -6.5% | -6.8% | 0.6% |